Adam Davidson, CEO of Trident Royalties, discusses offtake milestones and catalysts to boost FY24. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNSF.L Regulatory News (NSF)

  • There is currently no data for NSF

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Acquisition of George Banco, £225m term loan & RCF

3 Aug 2017 07:01

RNS Number : 9662M
Non-Standard Finance PLC
03 August 2017
 

 

 

Non-Standard Finance plc

('NSF' or the 'Group')

3 August 2017

Acquisition of George Banco

£225m new term loan facility

£35m new revolving credit facility

 

 

Highlights

 

·

NSF has agreed to acquire George Banco for £53.5m in cash

·

NSF is now the clear number two in the UK's fast growing guaranteed loans segment

·

Together with TrustTwo, the Group had a combined guaranteed loan book of c.£40m as at 30 June 2017, representing approximately 20% of the enlarged Group total

·

The acquisition is expected to be earnings enhancing in the first full year post-acquisition (2018)

·

In the 12 months to 31 May 2017, George Banco generated revenue of £9.3m and EBITDA of £4.1m

·

Acquisition and refinancing is via a new £225m six-year loan facility provided by institutional investors

·

Additional funding available via a new £35m revolving credit facility provided by RBS

 

NSF is pleased to announce that it has agreed to acquire George Banco Limited ('George Banco') from its existing shareholders for an enterprise value of £53.5m, payable in cash. Completion is expected in September 2017 and the acquisition is expected to be earnings enhancing in the first full year following completion.

 

Having launched in April 2014, George Banco has grown rapidly to become the number two player in the UK's growing guaranteed loans market, with a total net loan book of approximately £30m. As part of a larger Group, we believe there is scope to continue to develop the business further and to grow profits substantially.

 

To finance the acquisition and refinance all of the Group's existing debt facilities, as well as to provide additional funding to support future growth, NSF has secured a new £175m term loan facility (the 'Term Loan'), provided by a group of institutional investors, led by Alcentra Limited. The new six-year loan bears an interest rate of LIBOR plus 725 basis points per year with interest payable every six months. The same investors have also agreed to provide an additional committed facility of up to £50m under the same terms as the Term Loan. In addition, the Group has also secured a new £35m revolving credit facility ('RCF') provided by Royal Bank of Scotland.

 

Commenting on the acquisition and refinancing, John van Kuffeler, Group Chief Executive said:

 

"George Banco represents a transformative acquisition for the Group, putting NSF into the clear number two position in the fast-growth guaranteed loans segment. Complementing our existing TrustTwo brand, George Banco provides us with real scale and an opportunity to grow even faster.

 

"With leading positions in each of our chosen segments, we now have a stable, long-term funding platform from which we can finance our growth plans. We will continue to seek strategic opportunities in the UK's non-standard finance sector that meet our stringent criteria for growth and return on assets."

 

- Ends -

For more information:

 

Non-Standard Finance plc

John van Kuffeler, Group Chief Executive

Nick Teunon, Chief Financial Officer and Company Secretary

Peter Reynolds, Director, IR and Communications

 

+44 (0) 20 3869 9026

Bell Pottinger

Jonathan Hodgkinson

Aarti Iyer

Molly Stewart

+44 (0) 20 3772 2500

 

Interviews with John van Kuffeler, Chairman and Nick Teunon, Chief Financial Officer

Interviews with John van Kuffeler and Nick Teunon will be available as video and text from 7.00 am on 3 August 2017 on the Group's website: www.nonstandardfinance.com.

 

Analyst meeting, webcast, dial-in and conference call details

There will be an analyst meeting at 9.00 am on 3 August 2017 for invited UK-based analysts at the offices of JP Morgan, 60 Victoria Embankment, London, EC4Y 0JP (the entrance is in John Carpenter Street). The meeting will be simultaneously broadcast via webcast and conference call. To watch the live webcast, please register for access by visiting the Group's website www.nonstandardfinance.com. Details for the dial-in facility are given below. A copy of the webcast and slide presentation given at the meeting will be available on the Group's website later today.

 

Dial-in details to listen to the analyst presentation at 9.00 am, 3 August 2017

08.50 am

Please call +44 (0)330 336 9411

Access code

8462263

9.00 am

Meeting starts

 

All times are British Summer Time (BST).

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
ACQDGGDISXGBGRD
Date   Source Headline
10th Jul 20237:00 amRNSNotice of Delisting
7th Jul 20238:06 amRNSSuspension of Trading in Ordinary Shares
5th Jul 20233:18 pmRNSUpdate on Delisting and Suspension of Shares
23rd Jun 20232:51 pmRNSFiling of Annual General Meeting Resolutions
23rd Jun 20232:49 pmRNSResult of AGM
23rd Jun 20237:00 amRNSUpdate on Scheme, Delisting & Directorate Change
23rd May 20237:00 amRNSStandard form for notification of major holdings
18th May 20237:00 amRNSProposed Recapitalisation & Directorate Change 
28th Apr 20235:51 pmRNSReplacement: Update on scheme of arrangement
28th Apr 20233:33 pmRNSUpdate on scheme of arrangement
28th Apr 20238:21 amRNSAudited full year results to 31 December 2022
14th Apr 20237:00 amRNSProposed Release of Debt and Directorate Change
4th Apr 20234:14 pmRNSDirector/PDMR Shareholding
29th Mar 20234:35 pmRNSPrice Monitoring Extension
23rd Mar 20234:35 pmRNSPrice Monitoring Extension
17th Mar 20237:39 amRNSLaunch of Scheme & Proposed Recapitalisation
17th Mar 20237:00 amRNSScheme of Launch & Proposed Recapitalisation
13th Feb 20237:00 amRNS2022 Trading Statement
4th Jan 202310:15 amRNSDirector/PDMR Shareholding
3rd Jan 20234:40 pmRNSSecond Price Monitoring Extn
3rd Jan 20234:35 pmRNSPrice Monitoring Extension
4th Oct 20224:40 pmRNSSecond Price Monitoring Extn
4th Oct 20224:35 pmRNSPrice Monitoring Extension
29th Sep 20225:50 pmRNSDirector/PDMR Shareholding
29th Sep 20224:40 pmRNSSecond Price Monitoring Extn
29th Sep 20224:37 pmRNSPrice Monitoring Extension
28th Sep 20227:05 amRNSUpdate on Current Status and Regulatory matters
28th Sep 20227:05 amRNSUnaudited Half Year Results to 30 June 2022
27th Jul 20224:41 pmRNSSecond Price Monitoring Extn
27th Jul 20224:36 pmRNSPrice Monitoring Extension
22nd Jul 20224:40 pmRNSSecond Price Monitoring Extn
22nd Jul 20224:35 pmRNSPrice Monitoring Extension
19th Jul 20224:41 pmRNSSecond Price Monitoring Extn
19th Jul 20224:35 pmRNSPrice Monitoring Extension
6th Jul 20224:40 pmRNSSecond Price Monitoring Extn
6th Jul 20224:36 pmRNSPrice Monitoring Extension
4th Jul 20224:16 pmRNSDirector/PDMR Shareholding
15th Jun 20223:25 pmRNSFunding facilities update
26th May 20224:42 pmRNSFilings of AGM Resolutions
26th May 20222:49 pmRNSResults of Annual General Meeting
29th Apr 202212:00 pmRNSDirectorate Change
29th Apr 20227:00 amRNSAudited full year results to 31 December 2021
29th Apr 20227:00 amRNSAudited full year results to 31 December 2021
1st Apr 20224:40 pmRNSSecond Price Monitoring Extn
1st Apr 20224:35 pmRNSPrice Monitoring Extension
29th Mar 20229:26 amRNSDirector/PDMR Shareholding
17th Mar 20224:41 pmRNSSecond Price Monitoring Extn
17th Mar 20224:36 pmRNSPrice Monitoring Extension
16th Mar 20224:41 pmRNSSecond Price Monitoring Extn
16th Mar 20224:36 pmRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.